Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging
Stopped early · Not applicable
Conditions studied: Angina, Chest Pain
In brief
The primary goal of this study is to better understand how Transmyocardial Laser Revascularization (TMR) affects the functioning of the heart and, in turn, relieves angina in individuals with coronary heart disease using Magnetic Resonance (MR) images and Computed Tomography (CT) images in some patients.
Key facts
- Study ID
- NCT01287910
- Run by
- Piedmont Healthcare
- People needed
- 2
- Starts
- 2011-01-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2013-09-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female 18 years of age or over
- Patients with medically refractory, severe, class III or IV angina based on the Canadian Cardiovascular Society angina scale as determined by a physician
- Ejection fraction 25% or greater
- Patients with significant ischemia in the myocardium and who are NOT candidates for treatment by direct coronary revascularization methods (i.e., CABG or PCI)
- Ability and willingness to consent and Authorization for use of PHI
You may not qualify if…
- Patient cannot undergo a surgical procedure or general anesthesia
- Patient not eligible for CMR study
- Severe unstable angina
- Q-wave MI within 3 weeks prior to TMR
- NQWMI within 2 weeks prior to TMR
- Decompensated heart failure (class III/IV) at the time of procedure
- Known increased bleeding risk
- Implanted pacemaker or defibrillator
- Clinically unstable arrhythmia
- Not able or willing to adhere to the study tests and procedures
- Inability or unwillingness to consent and Authorization for use of PHI
Where it is running
- Piedmont Heart Institute — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.